| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/23/1999 | CA2324225A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 09/23/1999 | CA2323897A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/23/1999 | CA2322619A1 Medium and method for viral propagation and growth |
| 09/23/1999 | CA2288679A1 Process for the production of virus in cell cultures |
| 09/22/1999 | EP0943680A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/22/1999 | EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 09/22/1999 | EP0942928A1 Subunit respiratory syncytial virus vaccine preparation |
| 09/22/1999 | EP0594743B1 Continuous cell line and vaccine against avian coccidia |
| 09/22/1999 | CN1229434A Method of attenuating viruses |
| 09/22/1999 | CN1229358A Method for generating bi-RNA-virus from synthetic RNA transcripts |
| 09/21/1999 | US5955448 Method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 09/21/1999 | US5955342 Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
| 09/21/1999 | US5955341 Heterodimeric receptor libraries using phagemids |
| 09/21/1999 | US5955331 Recombinant retroviruses with amphotropic and ecotropic host ranges |
| 09/21/1999 | US5955264 Rapid and simple selection of complementary dna encoding proteinmutations which reduce binding; using expression vectors in host cells exposed to selection agents |
| 09/21/1999 | US5955256 Mixing with photosensitizer and blocking agent of cysteine, n-acetylcysteine, dithiothreitol, butylated hydroxytoluene, butylated hydroxyanisole, tyrosine, histidine, tryptophan, propyl gallate, or mercaptopropionyl glycine |
| 09/21/1999 | CA2063427C Rapid, versatile and simple system for expressing genes in eukaryotic cells |
| 09/21/1999 | CA1340762C Recombinant birth control vaccine |
| 09/16/1999 | WO1999046288A2 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 09/16/1999 | WO1999036511A3 Feline immunodeficiency virus gene therapy vectors |
| 09/16/1999 | WO1999015684A9 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 09/15/1999 | EP0941355A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia |
| 09/15/1999 | EP0941240A1 New picornaviruses, vaccines and diagnostic kits |
| 09/15/1999 | CN1228474A Process for production of recombination adenovirus |
| 09/14/1999 | US5952227 Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same |
| 09/14/1999 | US5952225 A packaging cell containing a polynucleotide which codes a portion of a selected retrovirus having at least the envelope protein; for producing vectors resistant to complement inactivation by serum; gene therapy |
| 09/14/1999 | US5952221 A virion having a drug-sensitivity gene and a second gene capable of providing ancillary effects to solid tumor cells; gene therapy and antitumor agents |
| 09/14/1999 | US5952216 A mutant human papillomavirus particle where aspartic acid is replaced by glutamic acid; vaccines |
| 09/14/1999 | US5952002 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/14/1999 | CA1340747C Hiv-2 virus variants |
| 09/10/1999 | WO1999045127A2 Enhanced prodrug activation |
| 09/10/1999 | WO1999045126A2 Enhanced prodrug activation |
| 09/10/1999 | WO1999045104A2 Purification of virus preparations |
| 09/10/1999 | WO1999044943A2 Vectors and viruses used in gene therapy |
| 09/10/1999 | CA2322664A1 Enhanced prodrug activation |
| 09/10/1999 | CA2322615A1 Virus preparations and methods |
| 09/09/1999 | DE19808889A1 Vektoren und Viren zur Gentherapie Vectors and viruses for gene therapy |
| 09/08/1999 | EP0939828A1 Herpesvirus saimiri as viral vector |
| 09/08/1999 | EP0939827A1 Lentiviral vectors |
| 09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 09/08/1999 | CN1228122A Method for immortalizing cells |
| 09/08/1999 | CN1228119A Immortalized cell lines for virus growth |
| 09/07/1999 | US5948675 Host-vector system which can be used in gene therapy |
| 09/07/1999 | US5948412 Vaccine for Moraxella catarrhalis |
| 09/07/1999 | US5948410 Animal cell culture |
| 09/07/1999 | CA2072982C Hepatitis a vaccines |
| 09/02/1999 | WO1999043842A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 09/02/1999 | WO1999043790A1 Method and apparatus for irradiating a biological fluid |
| 09/02/1999 | CA2792479A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2321995A1 Method and apparatus for irradiating a biological fluid |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0938679A2 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 09/01/1999 | EP0938579A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 09/01/1999 | EP0938555A1 Constructs and complexes of cyclin e |
| 08/31/1999 | US5945335 A nucleic acid molecule that functions as an accessory molecule for recombinant adeno-associated virus particle production; gene therapy for diabetes and hemophilia and anticarcinogenic agent |
| 08/31/1999 | US5945277 Determining the presence of four corners virus in a sample by reverse transcribing viral rna then amplifying the dna using primers, the detected amplified product indicates the presence of adult respiratory distess syndrome |
| 08/26/1999 | WO1999031257A3 Protein expression in baculovirus vector expression systems |
| 08/25/1999 | EP0937150A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 08/25/1999 | EP0937095A1 Targeted cytolysis of cancer cells |
| 08/25/1999 | CN1226924A Monoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
| 08/24/1999 | US5942235 Exogenous dna encoding an antigenic determinant of a pathogen; recombinant viruses and gene products are useful for cancer therapy |
| 08/19/1999 | WO1999041416A2 Compositions comprising viruses and methods for concentrating virus preparations |
| 08/19/1999 | WO1999041400A1 Methods for pseudoadenoviral vector production |
| 08/19/1999 | WO1999041399A1 Methods for purified aav vector production |
| 08/19/1999 | WO1999041398A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors |
| 08/19/1999 | WO1999041397A1 Anti-viral vectors |
| 08/19/1999 | WO1999041396A1 Use of negative regulation elements for nerve-specific expression of transgenes |
| 08/19/1999 | WO1999041360A1 Method for the development of an hiv vaccine |
| 08/19/1999 | WO1999041359A1 Modified adenovirus containing a fiber replacement protein |
| 08/19/1999 | WO1999031250A3 Constitutive expression of non-infectious hiv-like particles |
| 08/19/1999 | CA2723040A1 Compositions comprising viruses and methods for concentrating virus preparations |
| 08/19/1999 | CA2323011A1 Method for the development of an hiv vaccine |
| 08/19/1999 | CA2321220A1 Use of negative regulation elements for nerve-specific expression of transgenes |
| 08/19/1999 | CA2321135A1 Modified adenovirus containing a fiber replacement protein |
| 08/19/1999 | CA2321097A1 Anti-viral vectors |
| 08/19/1999 | CA2320513A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors |
| 08/19/1999 | CA2319212A1 Methods for purified aav vector production |
| 08/19/1999 | CA2318737A1 Methods for pseudoadenoviral vector production |
| 08/18/1999 | EP0935648A1 Improved adenovirus vectors |
| 08/17/1999 | US5939262 Ribonuclease resistant RNA preparation and utilization |
| 08/17/1999 | US5939073 Fish pancreatic disease virus |
| 08/12/1999 | WO1999040212A2 Bacteriophage vectors generated by bacteriophage/plasmid recombination |
| 08/12/1999 | WO1999040116A1 Process for expression of thyroid stimulating hormone receptor |
| 08/12/1999 | WO1999039734A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob |
| 08/12/1999 | WO1999039582A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/12/1999 | WO1999018226A9 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 08/12/1999 | WO1999015684A8 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 08/12/1999 | CA2751655A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/12/1999 | CA2327545A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob |
| 08/12/1999 | CA2320359A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/12/1999 | CA2318919A1 Bacteriophage vectors generated by bacteriophage/plasmid recombination |
| 08/11/1999 | EP0934423A2 Aav-dna helper virus sequences |
| 08/11/1999 | EP0934422A2 Gene therapy for congestive heart failure |
| 08/11/1999 | EP0699240B1 Gibbon ape leukemia virus-based retroviral vectors |
| 08/10/1999 | US5935934 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 08/05/1999 | WO1999038955A2 Mutant herpes simplex viruses and uses thereof |
| 08/05/1999 | WO1999022763A3 Encapsulated immunomodulators useful as vaccine adjuvants |
| 08/05/1999 | CA2319669A1 Mutant herpes simplex viruses and uses thereof |
| 08/04/1999 | EP0933429A1 Chimeric poxvirus comprising a retroviral vector genome |
| 08/04/1999 | EP0932695A2 Viral vectors and their uses |